▲ NIFTY 50 top gainers HDFCLIFE₹557.00▲ 5.05% TMPV₹314.50▲ 4.49% SBILIFE₹1,766.90▲ 4.06% DRREDDY₹1,175.00▲ 3.07% BEL₹395.45▲ 2.51% INDIGO₹4,845.00▲ 2.36% TATASTEEL₹187.29▲ 2.34% JIOFIN₹229.30▲ 1.98% ETERNAL₹322.35▲ 1.69% SHRIRAMFIN₹995.00▲ 1.63% ▼ NIFTY 50 top losers ONGC₹232.43▼ 1.85% TITAN₹4,841.00▼ 1.38% HDFCBANK₹713.00▼ 1.18% COALINDIA₹418.00▼ 1.01% HINDUNILVR₹1,942.20▼ 1.01% NESTLEIND₹1,370.60▼ 1.00% ICICIBANK₹1,347.60▼ 0.82% BAJAJ-AUTO₹11,500.00▼ 0.80% GRASIM₹3,173.10▼ 0.44% WIPRO₹166.40▼ 0.29% NSE most active PNB₹116.47▼ 0.28% ITC₹266.20▲ 0.78% KOTAKBANK₹416.50▲ 0.36% CANBK₹123.90▲ 0.57%

NSE ACUTAAS · BSE 543349 · Chemical Manufacturing · NIFTY 500

Acutaas Chemicals Share Price

Market closed · updated 25 Sep, 2:43 PM IST
₹3,283.70 ▲ +₹5.57 · 0.17% NSE · as of 25 Sep 2026, 3:45 AM · BSE ₹3,293.10
Today's range
₹3,228.70Low₹3,293.10High
52-week range
₹1,290.05Low · 1 Oct 2025₹3,735.00High · 6 Jul 2026

Acutaas Chemicals Overview

Where the price stands, how it has moved and how it sits against its averages.

Acutaas Chemicals shares last traded at ₹3,283.70 on the NSE, up 0.17% on the day. That is 12.1% below the 52-week high of ₹3,735.00 and 154.5% above the 52-week low of ₹1,290.05. The stock trades at 74.75× earnings, above the sector average of 36.18. Its market value is ₹27,000 Cr.

Price returns

1 Day▲ +0.17%
5 Days▼ −2.38%
This month▲ +3.31%
3 Months▼ −0.10%
6 Months▲ +29.20%
This year▲ +91.52%
1 Year▲ +125.17%

Against the market: 1 Month ▲ +3.77% · 3 Months ▲ +2.78% · 6 Months ▲ +29.97% · This year ▲ +118.12% · 1 Year ▲ +147.06%

Shading grows with the size of the move. Prices refresh every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next update from Mon 28 Sep, 9:15 AM.

Moving averages — price is above 3 of 6

  1. 10-day average₹3,334.78 ▼ price 1.5% below
  2. 5-day average₹3,332.00 ▼ price 1.4% below
  3. 50-day average₹3,301.71 ▼ price 0.5% below
  4. Today's price₹3,283.70
  5. 20-day average₹3,270.97 ▲ price 0.4% above
  6. 100-day average₹3,214.87 ▲ price 2.1% above
  7. 300-day average₹2,604.56 ▲ price 26.1% above

Averages above today's price sit higher on the ladder. Price above most of its averages is usually read as an upward trend.

Acutaas Chemicals Financial Results

Revenue and net profit in ₹ crore, with the full statements underneath.

Revenue₹ crore
1,339
Net profit₹ crore · losses below zero
356

Year by year

Fiscal yearRevenueGrowthNet profitNet marginEPSDividend
FY 2026 ₹1,339 Cr ▲ +33.0% ₹356 Cr 26.6% ₹43.51 ₹2.50
FY 2025 ₹1,007 Cr ▲ +40.3% ₹159 Cr 15.8% ₹19.81 ₹1.50
FY 2024 ₹717 Cr ▲ +16.3% ₹43 Cr 6.0% ₹5.83 ₹1.50
FY 2023 ₹617 Cr ▲ +18.6% ₹83 Cr 13.5% ₹11.43 ₹1.50
FY 2022 ₹520 Cr ▲ +54.7% ₹72 Cr 13.8% ₹10.52 ₹1.50
FY 2021 ₹336 Cr ▲ +42.5% ₹54 Cr 16.1% ₹7.41 ₹0.00
FY 2020 ₹236 Cr — ₹27 Cr 11.6% ₹3.77 ₹0.00

Balance sheet — FY26

Owes (liabilities)Shareholders' equity
17%
83%
  • Total assets₹1,984 Cr
  • Total liabilities₹330 Cr
  • Shareholders' equity₹1,654 Cr
  • Total debt₹36 Cr
  • Cash & investments₹225 Cr
  • Current ratio3.82×
  • Revenue growth, 5 yr31.84% a year
  • EPS growth, 5 yr42.48% a year
  • Operating margin (TTM)34.54%
  • Net margin (TTM)26.50%

Cash flow — FY26

Operating activities
▲ ₹292 Cr
Investing activities
▼ −₹266 Cr
Financing activities
▲ ₹4 Cr
Free cash flow
▼ −₹36 Cr
Net change in cash
▲ ₹30 Cr

Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.

Full financial statements, FY20–FY26
₹ croreFY20FY21FY22FY23FY24FY25FY26
Total revenue235.87336.21520.14616.73717.471,006.881,339.37
Cost of revenue130.20181.73275.60335.51416.23588.64616.27
Gross profit105.67154.48244.54281.22301.25418.24723.10
Operating expenses201.26264.14425.04505.72637.12801.42894.96
Operating income34.6172.0795.10111.0180.35205.45444.41
Depreciation3.524.1910.0812.3416.0626.6235.99
Profit before tax34.7571.7391.45112.1781.90216.16482.73
Tax7.2817.7319.5028.8833.1955.75126.36
Net profit27.4754.0071.9583.2942.77158.71356.26
EPS (₹)3.777.4110.5211.435.8319.8143.51
Dividend per share (₹)0.000.001.501.501.501.502.50

What Analysts Say

6 analysts

Recommendations from 6 analysts who cover Acutaas Chemicals.

Buy average rating 2.00 on a 1–5 scale

▲ 5 bullish (83.3%) · 0 hold (0.0%) · ▼ 1 bearish (16.7%)

Votes

Strong Buy
2 (33%)
Buy
3 (50%)
Hold
0 (0%)
Sell
1 (17%)
Strong Sell
0 (0%)

How the votes changed

Rating3M ago2M ago1M ago1W agoNow3-month change
Strong Buy43222 ▼ −2
Buy11333 ▲ +2
Hold00000 —
Sell11111 —
Strong Sell00000 —

Analyst ratings are opinions, not a guarantee of returns.

Acutaas Chemicals vs Peers

Side by side with other chemical manufacturing companies. The small bars compare each column.

CompanyPriceChangeMarket capP/EP/BROE (5 yr)Net marginDiv. yieldRating
Acutaas Chemicals ₹3,283.70 ▲ +0.17% ₹27,000 Cr 74.75 16.17 17.78% 26.50% 0.08% This stock
Asian Paints ₹2,404.05 ▲ +0.23% ₹2,30,596 Cr 58.09 12.06 24.22% 12.35% 1.02% Bearish
Solar Industries India ₹19,650.65 ▲ +0.70% ₹1,77,819 Cr 99.61 26.62 30.43% 17.65% 0.06% Neutral
Pidilite Industries ₹1,526.20 ▼ −0.25% ₹1,55,349 Cr 64.76 14.71 21.84% 16.92% 0.73% Moderately Bearish
SRF ₹2,531.70 ▲ +0.23% ₹75,046 Cr 44.57 6.07 15.85% 11.62% 0.31% Bearish
Linde India ₹6,152.30 ▼ −0.72% ₹52,469 Cr 110.53 14.22 — 21.69% 0.06% Bearish

Rating = the data provider's overall technical view of each peer. Company names link to their own pages.

Shareholding Pattern

Who owns Acutaas Chemicals shares, quarter by quarter (latest on top).

PromoterFIIMFOther
Jun '26
32.7%
21.6%
14.2%
31.6%
Mar '26
Dec '25
Sep '25
HolderSep '25Dec '25Mar '26Jun '26Change
Promoter32.66%32.66%32.66%32.66% 0.00 pts
FII16.84%16.67%19.48%21.61% ▲ +2.13 pts
MF15.81%15.11%13.86%14.17% ▲ +0.31 pts
Other34.69%35.56%34.00%31.56% ▼ −2.44 pts

Acutaas Chemicals Key Metrics

Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.

Acutaas ChemicalsBenchmarkComfortable → stretched

Valuation Is the price reasonable?

P/E (TTM)Price ÷ yearly earnings per share
74.75
▲ 107% above the sector average of 36.18
P/E, 12-month rangeLow 39.73 · high 163.98
28%
Today's P/E sits 28% of the way from its low to its high
P/BPrice ÷ book value per share
16.17
P/SPrice ÷ sales per share
18.29
P/CFPrice ÷ cash flow per share
62.90
PEGP/E ÷ earnings growth (≈1 is fair)
1.24

Profitability Of every ₹100 of sales, how much is kept?

Gross marginKept after the cost of goods
58.42%
▲ above its 5-yr average of 46.86%
Operating marginKept after running costs
34.54%
▲ above its 5-yr average of 22.29%
Pre-tax marginKept before tax
36.16%
▲ above its 5-yr average of 23.44%
Net marginKept as profit
26.50%
▲ above its 5-yr average of 17.16%

Returns & efficiency How well does it use its money?

Return on equityProfit on shareholders' money
24.05%
▲ above its 5-yr average of 17.78%
Return on assetsProfit on everything it owns
20.17%
▲ above its 5-yr average of 13.68%
Return on investmentProfit on long-term capital
23.50%
▲ above its 5-yr average of 16.98%

Growth Is the business getting bigger?

Revenue — last 12 months
+40.9%
▲ growing (off the scale)
Revenue — 3 yr, a year
+29.5%
▲ growing (off the scale)
Revenue — 5 yr, a year
+31.8%
▲ growing (off the scale)
EPS — last 12 months
+102.5%
▲ growing (off the scale)
EPS — 3 yr, a year
+56.2%
▲ growing (off the scale)
EPS — 5 yr, a year
+42.5%
▲ growing (off the scale)
Dividend — 3 yr, a year
+18.6%
▲ growing
Book value — 5 yr, a year
+54.6%
▲ growing (off the scale)

Financial strength Can it pay its bills and debts?

Debt to equityBorrowings for every ₹1 of shareholders' money
0.02×
✓ Low debt
Current ratioShort-term assets for every ₹1 due within a year
3.82×
✓ Comfortable
Quick ratioLike the current ratio, without inventory
2.76×
✓ Comfortable
Interest coverOperating profit ÷ interest to pay
133.90×
✓ Strong
Payout ratioShare of profit paid as dividend
3.45%
• Keeps most

Per share What each share stands for

EPS (TTM)
₹47.06
Book value
₹201.90
Cash flow
₹51.78
Dividend
₹2.50
Revenue
₹178.09

The share price is 16.26× the book value behind each share.

Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.

All 109 metrics from the data provider

Valuation

P/E excluding extraordinary items, most recent fiscal year75.04
Current Dividend Yield - Common Stock Primary Issue, LTM0.08
Price to Book - most recent fiscal year16.17
P/E Basic excluding extraordinary items - TTM74.75
P/E including extraordinary items - TTM69.39
P/E excluding extraordinary items low, trailing 12 months39.73
Price to Tangible Book - most fiscal year17.34
Dividend Yield - 5 Year Average0.16
Price to sales - most recent fiscal year19.96
Dividend Yield - indicated annual dividend divided by closing price0.08
Price to Cash Flow per share - trailing 12 month62.90
Peg Ratio1.24
P/E Normalized, most recent fiscal year75.04
P/E excluding extraordinary items high, trailing 12 months163.98
P/E excluding extraordinary items, most recent fiscal year quarter69.39
Price to sales - trailing 12 month18.29
Net Debt, LFY−1,892.38

Per share

Dividend Per Share - 5 year average1.70
Cash Flow per share - trailing 12 month51.78
Cash Flow per share - most recent fiscal year47.92
EPS including extraordinary items - trailing 12 month47.06
EPS including extraordinary items - most recent fiscal year43.51
EBITD per share - trailing 12 month66.10
Revenue/share - trailing 12 month178.09
EPS excluding extraordinary items - trailing 12 month47.06
EPS Basic excluding extraordinary items - most recent fiscal year43.51
EPS Basic excluding extraordinary items - trailing 12 month47.18
Book value per share - most recent fiscal year201.97
Dividend per share - most recent fiscal year2.50
Revenue/share - most recent fiscal year163.60
EPS Normalized - most recent fiscal year43.51
Book value (tangible) per share - most recent fiscal year188.35
Dividends per share - trailing 12 month2.50
EPS excluding extraordinary items - most recent fiscal year43.51
Cash per share - most recent fiscal year27.46

Margins

Operating margin - trailing 12 month34.54
Gross Margin - 5 year average46.86
Operating margin - 1st historical fiscal year33.18
Operating Margin - 5 year average22.29
Net Profit Margin % - 1st historical fiscal year26.61
Gross Margin - 1st historical fiscal year53.99
Net Profit Margin % - trailing 12 month26.50
Net Profit Margin - 5 year average17.16
Pretax Margin - 5 year average23.44
Pretax margin - 1st historical fiscal year36.04
Pretax margin - trailing 12 month36.16
Free Operating Cash Flow/Revenue, 5 Year Average−9.23
Gross Margin - trailing 12 month58.42

Growth

EPS Change %, TTM over TTM102.53
Revenue growth rate, 5 year31.84
EPS growth rate, 5 year42.48
Revenue Change % - most recent quarter 1 year ago59.08
Growth rate% - dividend, 3 year18.56
Growth rate% - EPS, 3 year56.15
Revenue/share (5 yr growth)28.81
Tangible Book Value, Total Equity, 5 Year CAGR61.30
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR43.59
Capital Spending growth rate, 5 year25.21
Revenue Change %, TTM over TTM40.90
Growth rate% - Revenue, 3 year29.50
Book value per share growth rate, 5 year54.55
EPS Change % - most recent quarter 1 year ago67.10
Net Profit Margin growth rate, 5 year10.62
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR44.56
Total Debt, 5 Year CAGR−23.59

Financial strength

Free Cash Flow - most recent fiscal year−480.86
LT debt/equity - most recent fiscal year0.01
Quick ratio - most recent fiscal year2.76
Payout ratio - trailing 12 month3.18
Current ratio - most recent fiscal year3.82
Current EV/Free Cash Flow, LFY510.59
Total debt/total equity - most recent fiscal year0.02
Net Interest coverage - trailing 12 month133.90
Payout ratio - most recent fiscal year3.45

Returns & efficiency

Return on average equity - 5 year average17.78
Net Income/employee - trailing 12 month38,46,589.00
Revenue/employee - most recent fiscal year1,42,03,250.00
Return on investment - most recent fiscal year23.50
Return on average assets - most recent fiscal year20.17
Receivables turnover - most recent fiscal year4.10
Inventory turnover - most recent fiscal year2.82
Revenue/employee - trailing 12 month1,45,16,430.00
Return on average assets - 5 year average13.68
Net Income/employee - most recent fiscal year37,79,102.00
Asset turnover - most recent fiscal year0.76
Return on average equity - most recent fiscal year24.05
Return on investment - 5 year average16.98

Price & volume

Market Cap26,878.26
52 week Low Date1 Oct 2025
Price - 1 Day % Change1.60
Relative (S&P500) price percent change - 13 week2.78
Avg trading volume last 10 days0.41
Price - 13 week price percent change−0.10
Price - 52 week price percent change125.17
Avg Trading Volume Last 3 months7.75
Price - 5 Day % Change−2.38
Price % Change Month To Date3.31
Relative (S&P500) price percent change - 04 week3.77
52 week High Date6 Jul 2026
Price - 26 week price percent change29.20
PDATE23 Sep 2026
Price - YTD price percent change91.52
Relative (S&P500) price percent change - 52 week147.06
NPRICE3,265.20
Relative (S&P500) price percent change - 26 week29.97
52 week Low1,302.00
52 week High3,740.00
Beta0.34
Relative (S&P500) price percent change - Year to Date118.12

Dividends & Corporate Events

Payouts to shareholders, splits and bonus issues, and company meetings — newest first.

Dividend per share₹ per share, by fiscal year
₹2.50
  • Dividend yield0.08%
  • Payout ratio3.45%
  • 5-year average dividend₹1.70 a share
  • Latest dividend₹2.50 per share · 17 Sep 2026

Corporate calendar

  • MeetingAnnual General Meeting
  • Dividend₹2.50 per share · 50% · Final dividend
  • BoardQuarterly Results
  • BoardAudited Results & Final Dividend
  • BoardQuarterly Results
  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • Dividend₹1.50 per share · 30% · Final dividend
Show 12 older events
  • BoardQuarterly Results
  • MeetingExtraordinary General Meeting
  • BoardAudited Results & Final Dividend
  • SplitStock split — face value ₹10 → ₹5
  • MeetingPostal Ballot
  • BoardStock Split
  • BoardQuarterly Results
  • MeetingAnnual General Meeting
  • Dividend₹3.00 per share · 30% · Final dividend
  • MeetingAnnual General Meeting
  • Dividend₹3.00 per share · 30% · Final dividend
  • Dividend₹3.00 per share · 30% · Final dividend

About Acutaas Chemicals

Chemical Manufacturing

Acutaas Chemicals Limited, formerly Ami Organics Limited, is an India-based company, which is engaged in the manufacturing of pharma intermediates and specialty chemicals. It is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other industries. It manufactures pharma intermediates for certain active pharmaceutical ingredients (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It has developed and commercialized over 610 plus products, including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas.

Key people

  • Nareshkumar Ramjibhai PatelExecutive Chairman of the Board and Managing Director
  • Bhavin N. ShahChief Financial Officer
  • Chetansinh ParmarChief Information Security Officer
  • Ekta Kumari SrivastavaCompany Secretary and Compliance Officer
  • Ram Mohan LokhandeWhole Time Director
  • Virendra Nath MishraWhole Time Director

Company facts

  • NSE symbolACUTAAS
  • BSE code543349
  • ISININE00FF01025
  • IndustryChemical Manufacturing
  • IndexNIFTY 500
  • Market cap₹27,000 Cr
  • Revenue (FY26)₹1,339 Cr
  • Net profit (FY26)₹356 Cr

In the News

Recent headlines about Acutaas Chemicals — they open on Mint in a new tab.

Stock data comes from the exchange feed via our data provider and may be delayed. It is for information only and is not a recommendation to buy or sell. See all stocks →

Frequently Asked Questions

Acutaas Chemicals (NSE: ACUTAAS) last traded at ₹3,283.70 on the NSE, up 0.17% (₹5.57) on the day, as of 25 Sep 2026, 3:45 AM. On the BSE it was ₹3,293.10. The day's range was ₹3,228.70 – ₹3,293.10.

Acutaas Chemicals's 52-week high is ₹3,735.00 (6 Jul 2026) and its 52-week low is ₹1,290.05 (1 Oct 2025). At ₹3,283.70 the share is 12.1% below its high and 154.5% above its low.

Acutaas Chemicals's market capitalisation is ₹27,000 Cr (₹27,000 Cr). It is part of the NIFTY 500 index.

Acutaas Chemicals's P/E ratio (trailing 12 months) is 74.75. The sector average is 36.18, so investors pay 107% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹47.06.

Acutaas Chemicals shares are up 125.17% over the last year, up 91.52% so far this year, up 29.20% over 6 months, down 0.10% over 3 months. Over the last year the stock did 147.06% better than the market.

In FY26 (year to Mar 2026), Acutaas Chemicals reported revenue of ₹1,339 Cr (up 33.02% on the year before) and a net profit of ₹356 Cr. Earnings per share were ₹43.51.

Yes. Acutaas Chemicals's latest dividend is ₹2.50 per share (50%, final dividend), with an ex-date of 17 Sep 2026. The dividend yield is 0.08%. It has paid 5 dividends in the records shown on this page.

Of 6 analysts covering Acutaas Chemicals, 5 are bullish (2 strong buy, 3 buy), 0 say hold and 1 are bearish. The consensus is Buy (average rating 2.00 on a scale where 1 is Strong Buy and 5 is Strong Sell). Analyst views are opinions, not a guarantee.

As of Jun 2026: Promoter 32.66%, FII 21.61%, MF 14.17%, Other 31.56%.

Acutaas Chemicals's listed peers in Chemical Manufacturing include Asian Paints, Solar Industries India, Pidilite Industries, SRF, Linde India. By market capitalisation it ranks #6 of 6 in this group.